Kardiologia polska · 2003
Plasma endothelin-1 in patients with stable or unstable angina.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zuk-Popiołek Izabela, Flak Zbigniew, Francuz Tomasz, Tendera Michał
Аннотация
BACKGROUND: It has been documented that an elevated endothelin-1 (ET-1) plasma concentration is associated with an increased risk of serious coronary events and the presence of angiographically documented coronary artery disease (CAD). The results of a few studies which examined ET-1 plasma level in patients with stable or unstable angina, were inconclusive.
AIM: To assess whether ET-1 blood concentration measured in the coronary sinus and peripheral vein is associated with clinical symptoms in patients with multi-vessel CAD.
METHODS: The study group consisted of 23 patients with multi-vessel CAD of whom 11 had unstable angina and 12 - stable angina. Both groups were matched with regard to age, gender and the presence of cardio-vascular risk factors. Blood samples for ET-1 assessment were taken during coronary angiography simultaneously from the coronary sinus and femoral vein. ET-1 was measured using an immunoenzymatic method.
RESULTS: ET-1 plasma level in the peripheral venous circulation was similar in patients with unstable or stable angina (0.45+/-0.18 pmol/L versus 0.46+/-0.14 pmol/L, NS) whereas ET-1 level in the coronary sinus was significantly higher in patients with unstable angina (1.44+/-0.47 pmol/L versus 0.34+/-0.17 pmol/L, p<0.05).
CONCLUSIONS: ET-1 concentration in the coronary sinus is significantly higher in patients with unstable rather than stable angina which confirms the role of ET-1 in the pathogenesis of CAD. Our results suggest a possible future role of endothelin receptor blockers in the treatment of patients with unstable angina.
AIM: To assess whether ET-1 blood concentration measured in the coronary sinus and peripheral vein is associated with clinical symptoms in patients with multi-vessel CAD.
METHODS: The study group consisted of 23 patients with multi-vessel CAD of whom 11 had unstable angina and 12 - stable angina. Both groups were matched with regard to age, gender and the presence of cardio-vascular risk factors. Blood samples for ET-1 assessment were taken during coronary angiography simultaneously from the coronary sinus and femoral vein. ET-1 was measured using an immunoenzymatic method.
RESULTS: ET-1 plasma level in the peripheral venous circulation was similar in patients with unstable or stable angina (0.45+/-0.18 pmol/L versus 0.46+/-0.14 pmol/L, NS) whereas ET-1 level in the coronary sinus was significantly higher in patients with unstable angina (1.44+/-0.47 pmol/L versus 0.34+/-0.17 pmol/L, p<0.05).
CONCLUSIONS: ET-1 concentration in the coronary sinus is significantly higher in patients with unstable rather than stable angina which confirms the role of ET-1 in the pathogenesis of CAD. Our results suggest a possible future role of endothelin receptor blockers in the treatment of patients with unstable angina.